This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,940.59 firm fixed-price delivery order is for the supply of fluticasone propionate HFA 220 mcg 12 gm inhalers. The contract has a period of performance through December 11, 2024 and was awarded on December 10, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical, which enables the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition. This contract supports the DLA's mission to provide medical commodities, including specialty medications, generic drugs, vaccines, and other critical supplies, to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/11/25, 9:44 AM